Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-02-05 @ 5:36 PM
Study NCT ID:
NCT03935334
Status:
COMPLETED
Last Update Posted:
2021-02-04
First Post:
2019-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors
Sponsor:
AryoGen Pharmed Co.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hemophilia A or B With Inhibitor | View |
Keywords: